Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

AKR1C3 As a Therapeutic Target to Overcome Erlotinib Resistance in Lung Adenocarcinoma

William C. Cho, Kwan P. Li,Chi F. Wong,King Y. Fung,James C. H. Chow,Ka M. Cheung, Jeffrey C. H. Chan,Eunice Y. T. Lau

Military Medical Research（2025）

Cited 0|Views20
Key words
AKR1C3,Erlotinib resistance,Epidermal growth factor receptor (EGFR) mutation,Lung adenocarcinoma (LUAD),Therapeutic target
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined